BlackRock’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.4M Sell
702,880
-2,729,819
-80% -$75.5M ﹤0.01% 3001
2025
Q1
$76.2M Sell
3,432,699
-139,164
-4% -$3.09M ﹤0.01% 2140
2024
Q4
$70.7M Sell
3,571,863
-245,393
-6% -$4.85M ﹤0.01% 2230
2024
Q3
$95.4M Sell
3,817,256
-773,880
-17% -$19.3M ﹤0.01% 2089
2024
Q2
$85.7M Buy
4,591,136
+397,229
+9% +$7.42M ﹤0.01% 2095
2024
Q1
$82.7M Buy
4,193,907
+1,013,319
+32% +$20M ﹤0.01% 2138
2023
Q4
$55.8M Buy
3,180,588
+62,280
+2% +$1.09M ﹤0.01% 2368
2023
Q3
$54.2M Sell
3,118,308
-42,116
-1% -$732K ﹤0.01% 2323
2023
Q2
$44.5M Sell
3,160,424
-225,736
-7% -$3.18M ﹤0.01% 2503
2023
Q1
$36.4M Sell
3,386,160
-195,519
-5% -$2.1M ﹤0.01% 2612
2022
Q4
$53.7M Sell
3,581,679
-46,781
-1% -$701K ﹤0.01% 2391
2022
Q3
$46.6M Buy
3,628,460
+93,103
+3% +$1.2M ﹤0.01% 2468
2022
Q2
$34.3M Buy
3,535,357
+41,032
+1% +$398K ﹤0.01% 2713
2022
Q1
$34.7M Buy
3,494,325
+10,473
+0.3% +$104K ﹤0.01% 2759
2021
Q4
$41M Buy
3,483,852
+363,530
+12% +$4.28M ﹤0.01% 2747
2021
Q3
$35.5M Buy
3,120,322
+621,032
+25% +$7.07M ﹤0.01% 2852
2021
Q2
$34.8M Buy
2,499,290
+248,679
+11% +$3.46M ﹤0.01% 2897
2021
Q1
$41.7M Buy
2,250,611
+61,381
+3% +$1.14M ﹤0.01% 2702
2020
Q4
$38.7M Buy
2,189,230
+359,711
+20% +$6.36M ﹤0.01% 2575
2020
Q3
$28M Buy
1,829,519
+632,699
+53% +$9.69M ﹤0.01% 2608
2020
Q2
$30.5M Buy
1,196,820
+263,807
+28% +$6.72M ﹤0.01% 2529
2020
Q1
$14.4M Sell
933,013
-15,444
-2% -$239K ﹤0.01% 2744
2019
Q4
$10.5M Sell
948,457
-169,462
-15% -$1.87M ﹤0.01% 3183
2019
Q3
$9.51M Buy
1,117,919
+10,828
+1% +$92.1K ﹤0.01% 3199
2019
Q2
$15M Buy
1,107,091
+139,072
+14% +$1.88M ﹤0.01% 2980
2019
Q1
$17.5M Buy
968,019
+322,908
+50% +$5.83M ﹤0.01% 2801
2018
Q4
$18.1M Buy
645,111
+194,538
+43% +$5.46M ﹤0.01% 2764
2018
Q3
$11.5M Buy
450,573
+440,573
+4,406% +$11.2M ﹤0.01% 3144
2018
Q2
$173K Buy
+10,000
New +$173K ﹤0.01% 4283